Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

1,247.044
+7.1130.57%
Number of Gainers:10
Number of Losers:4
Number of Flat:4
PE:- -
High:1,252.015
Open:1,239.856
Low:1,231.231
Close:1,239.931
Volume:439.91M
Turnover:3.48B
Market Cap:834.67B
Float Cap:701.58B

Loading ...

Deep Cooperation Between Factories and Ports: How Shenshan Accelerates Manufacturing-Services Synergy

Deep News
·
2 hours ago

Byd Company Limited's Flash Charging Android App Launches Ahead of Schedule: Features Plug-and-Charge and Contactless Payment with Transparent Pricing

Deep News
·
Yesterday

CSPC Pharmaceutical Group (SEHK:1093) Valuation Check After New Long-Acting Obesity And Pain Drug Trial Approvals

Simply Wall St.
·
Yesterday

DanNuo Pharma's Commercialization Challenge: R&D Spending Declines, Nearly 800 Million Yuan Partnership Hides Performance Clauses

Deep News
·
Yesterday

HENLIUS's Biosimilar HLX11 Receives Positive CHMP Review from EMA

Stock News
·
Feb 27

TYK MEDICINES-B Announces RMB 83.5 Million Capital Injection into Subsidiary

Stock News
·
Feb 27

Shanghai Junshi Biosciences - FY Prelim Net Loss Attributable RMB874.4 Mln

THOMSON REUTERS
·
Feb 27

Shanghai Junshi Biosciences - FY Prelim Total Operating Income RMB2.50 Bln

THOMSON REUTERS
·
Feb 27

STAR 50 Index Constituent Shuffle: Three Stocks Including Junshi Biosciences Removed, Effective Post-Market March 13

Stock News
·
Feb 27

AH Share Premium Rankings as of February 27th

Stock News
·
Feb 27

Liu Qiangdong's Yacht Venture Sets Sail from Zhuhai

Deep News
·
Feb 27

CSPC Pharmaceutical to Sell 30% Stake in Guoxin Huijin for 230 Million Yuan

MT Newswires Live
·
Feb 27

CanSino Biologics' Preliminary Figures Show Return to Profit in 2025; Shares Up 6%

MT Newswires Live
·
Feb 27

Wang Leehom Spotted at BYD Executive Dinner, Sparking Endorsement Speculation

Deep News
·
Feb 27

Pharmaceutical Industry Update: Key Developments on February 27

Deep News
·
Feb 27

Why Are Business Leaders from Xu Yangtian to Liu Qiangdong Choosing Guangdong in 2026? | Pearl River Delta Insights

Deep News
·
Feb 26

Fosun Pharma Gets Regulatory Nod for 6 Billion Yuan Bond Issue

MT Newswires Live
·
Feb 26

Yixintang to Capitalize on Market Opportunities and Expand Business Boundaries for Healthcare-Consumer Integration

Deep News
·
Feb 26

FOSUN PHARMA Secures Regulatory Approval for Bond Offering to Professional Investors

Stock News
·
Feb 26

How Can a Company Reign Without Mines? Jinlong Rare Earth's IPO on Beijing Stock Exchange: Backed by Xiamen Tungsten, Tied to BYD, Focused on Deep Processing

Deep News
·
Feb 26